MedTrace Logo

Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia

NCT01909154 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to confirm the security, and detect the effect of the local administration in damaged nervous tissue, of autologous bone marrow stromal cells.

Conditions

  • Spinal Cord Injury

Interventions

BIOLOGICAL

Mesenchymal stromal cell therapy

Stem cells administration locally

Sponsors & Collaborators

  • Puerta de Hierro University Hospital

    lead OTHER

Principal Investigators

  • Jesus JV Vaquero Crespo, Dr. · Hospital Universitario Puerta de Hierro-Majadahonda

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-04-30
Completion
2015-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01909154 on ClinicalTrials.gov